# Asklepios BioPharmaceutical: Biopharma, Easter Bush, United Kingdom

> Asklepios BioPharmaceutical: Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic...

Source: https://millionrounds.com/startup/asklepios-biopharmaceutical (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Biopharma startup](https://millionrounds.com/companies)

# Asklepios BioPharmaceutical

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

Email

Funding reported Last round: Grant

Biopharma Easter Bush, United Kingdom

Follow Asklepios BioPharmaceutical and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fasklepios-biopharmaceutical)

Company summary

- **Founded:** 2001 25 years old
- **Team:** 501 201 to 1,000 people
- **Funding reported:** 241.8M as listed, currency not stated
- **Last round:** Grant Sept 2020

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Asklepios BioPharmaceutical has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Asklepios BioPharmaceutical raised

Funding, as reported

Reported in all **241.8M** in the source's currency

Rounds **4**

Last round **Grant**

Last round date **Sept 2020**

Investors listed **4**

## On a portfolio page

Investors who name them

- [Vida Ventures](https://millionrounds.com/fund/vida-ventures-llc)

Each firm lists Asklepios BioPharmaceutical on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biopharma in United Kingdom

Startups like it

- [**Mereo Biopharma** London · founded 2015](https://millionrounds.com/startup/mereo-biopharma)
- [**Autolus** London](https://millionrounds.com/startup/autolus)
- [**Aiolos Bio** London · founded 2023](https://millionrounds.com/startup/aiolos-bio)
- [**Genomics** Oxford · founded 2014](https://millionrounds.com/startup/genomics-2)
- [**Touchlight Genetics** founded 2007](https://millionrounds.com/startup/touchlight-genetics)
- [**Canton Strategic Holdings** Chester](https://millionrounds.com/startup/canton-strategic-holdings)
- [**Resolution Therapeutics** London · founded 2017](https://millionrounds.com/startup/resolution-therapeutics)
- [**PredictImmune** Cambridge · founded 2017](https://millionrounds.com/startup/predictimmune)

## Is this your company?

Add your raise, your deck and your story, and put Asklepios BioPharmaceutical in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)
